Genetic Technologies Ltd (GENE) 4.86 $GENE Gene
Post# of 64072
Genetic Tech gets capital raise from U.S. investors
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 12:10PM CST
GENE: 4.86 (-1.39)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST
SSH: 4.03 (-1.32), ONCY: 0.90 (-0.15), LTM: 66.32 (+8.65), LEDS: 1.03 (-0.13), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), EXAS: 24.50 (+2.07), DRRX: 1.64 (+0.30), DRAD: 4.88 (+0.48), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), ICEL: 6.61 (+0.99), BORN: 1.23 (-0.32), DMD: 5.95 (+0.70), AVEO: 1.50 (+0.08), CALA: 14.67 (+1.36), MTL: 1.53 (-0.30), CKP: 11.37 (-2.06), ERII: 2.79 (-0.47)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:15AM CST
NGL: 27.04 (-1.94), FNSR: 22.23 (+1.90), SSH: 4.03 (-1.32), YY: 57.76 (+2.59), CNAT: 6.05 (-0.54), ASTI: 1.43 (-0.02), CLDN: 24.00 (+2.54), AXN: 1.49 (+0.37), VMEM: 3.59 (-0.40), BLRX: 2.12 (-0.69), GENE: 4.86 (-1.39), OREX: 7.10 (-0.91), SKUL: 10.40 (-0.67), CALA: 14.67 (+1.36), AVEO: 1.50 (+0.08), MSO: 4.96 (+0.09), GALE: 1.88 (-0.12), CKP: 11.37 (-2.06)
New chief at Genetic Tech
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 6:48AM CST
GENE: 4.86 (-1.39)
Genetic Technologies Remains Among Most Difficult To Borrow Names
Interactive Brokers - at Seeking Alpha - Tue Feb 24, 12:46AM CST
Genetic Technologies Limited (NASDAQ: GENE ) continues to be one of the most sought after borrows, and while liquidity remains scarce, what little supply is available to borrow is expensive. Although the price of GENE shares has come down...
GPRO: 40.13 (-0.95), TSLA: 193.88 (-6.75), CYBR: 59.78 (-3.09), MNKD: 5.47 (-0.26), GENE: 4.86 (-1.39), BLDP: 2.29 (-0.06), WPRT: 5.16 (-0.21), ATOS: 1.97 (-0.04), SGNL: 2.70 (-0.11), RIG: 15.52 (-0.48), OPK: 14.11 (-0.21), PSTR: 3.58 (-0.17), LINE: 11.86 (-0.13), ZU: 13.69 (+0.41)
A Recent Healthcare IPO That Could Lead To Big Gains For Investors On Improved Care For Newborns
Edward Vranic, CFA - at Seeking Alpha - Mon Feb 23, 3:06PM CST
GENE: 4.86 (-1.39), BABY: 35.54 (-0.45), CAPN: 7.11 (-0.26)
Top Funds' Activity In Q4 2014
Leo Kolivakis - Seeking Alpha - Fri Feb 20, 2:04PM CST
Svea Herbst-Bayliss and Sam Forgione of Reuters report, Top U.S. hedge funds cut Apple stakes ahead of all-time high : Top U.S. hedge fund management firms, including David Einhorn's Greenlight Capital and Philippe Laffont's Coatue Management,...
HK: 1.77 (-0.18), XLB: 50.46 (-0.69), GREK: 11.82 (-0.56), XBI: 224.72 (-2.85), IBB: 342.36 (-5.31), NBG: 1.43 (-0.08), RRC: 48.75 (-1.01), RIG: 15.52 (-0.48), XLK: 42.39 (-0.53), SPR: 49.11 (-0.52), TWTR: 46.75 (-0.60), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38), BHI: 60.92 (-1.18), XLE: 76.78 (-1.40), DVN: 59.18 (-1.65), FEYE: 42.83 (-1.08), XEC: 109.44 (-1.66), GSG: 20.44 (-0.25), NFLX: 454.12 (-13.53), GENE: 4.86 (-1.39), ROSG: 3.24 (-0.04), SBIO: 29.86 (-0.22), QQQ: 107.41 (-1.23), IDRA: 4.68 (-0.21), IWM: 121.17 (-1.55), BABA: 84.40 (-1.70)
Traders smitten with tiny thinly-traded biotechs
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:44AM CST
GENE: 4.86 (-1.39), HTBX: 7.35 (+0.53), SGNL: 2.70 (-0.11), ROSG: 3.24 (-0.04), TTPH: 37.09 (-1.80), ONCY: 0.90 (-0.15), CLRX: 1.15 (-0.10), MELA: 1.83 (+0.02), AKAO: 10.32 (-0.11), WGBS: 4.71 (-0.03), EGRX: 37.63 (-0.37)
Life Sciences Tools and Services Stocks Under Review -- Agilent Technologies, Genetic Technologies, Thermo Fisher Scientific, Affymetrix, and Sequenom
PR Newswire - Thu Feb 19, 7:55AM CST
Editor Note: For more information about this release, please scroll to bottom.
GENE: 4.86 (-1.39), SQNM: 3.58 (-0.04), TMO: 128.51 (-2.95), A: 41.53 (-0.69), AFFX: 11.81 (-0.38)
Stock Futures Show Mild Losses; Boston Scientific Bolts Higher
at Investor's Business Daily - Wed Feb 18, 8:16AM CST
Stock futures angled lower Wednesday, with some added pressure from weak housing and producer price data. Dow futures nosed down 23.6 points below fair market value. Nasdaq 100 and S&P 500 futures were down about 2.9 points each. The stock market...
GENE: 4.86 (-1.39), JACK: 96.25 (-1.30), BSX: 16.56 (-0.41), JNJ: 100.11 (-2.41), FLY: 15.14 (-0.21), ANGI: 6.80 (+0.08), PBPB: 12.89 (-0.09)
Genetic Technologies Analyst Report: No news drives GENE up 30% Issued by BrokerBank, Securities, Inc.
PR Newswire - Tue Feb 17, 6:00AM CST
Genetic Technologies Ltd. (NASDAQ: GENE) a genetic testing service provider based in Melbourne, AU recorded a surge in share price over the last trading day of the past week. The share price appreciated as much as 50% during intraday trading on volume of nearly 40 million shares. The sudden onset of interest in this particular stock is undetermined but may be the result of several theories discussed in the detailed report.
GENE: 4.86 (-1.39)
Recent Developments at Pharma Companies: Special Research on Discovery Labs, Enzon, Fate Therapeutics, Genetic Technologies, and Genocea Biosciences
PR Newswire - Mon Feb 16, 7:20AM CST
Editor Note: For more information about this release, please scroll to bottom.
GENE: 4.86 (-1.39), FATE: 5.07 (-0.01), ENZN: 1.10 (-0.01), GNCA: 8.46 (-0.14), DSCO: 1.78 (+0.02)
Wafergen Bio gets some Gene Tech love
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 2:47PM CST
GENE: 4.86 (-1.39), SGNL: 2.70 (-0.11), WGBS: 4.71 (-0.03)